Moisture curable composition with amino acids

ABSTRACT

The present invention provides curable compositions comprising non-tin metal accelerators that accelerate the condensation curing of moisture-curable silicones/non-silicones. In particular, the present invention provides an accelerator comprising amino acid compounds that are suitable as replacements for organotin in sealant and RTV formulations.

CROSS REFERENCE TO RELATED APPLICATIONS

The present application claims priority to and the benefit of U.S. Provisional Patent Application No. 61/872,111, entitled “Moisture Curable Compounds With Amino Acids,” filed on Aug. 30, 2013, the disclosure of which is incorporated herein by reference in its entirety.

FIELD

The present invention relates to curable compositions comprising curable polymers having reactive, silyl groups and a non-toxic condensation catalyst based on amino acid compounds. In particular, the present invention provides curable compositions comprising amino acid compounds as alternatives to organotin catalysts.

BACKGROUND

Moisture curable compositions crosslink upon exposure to moisture, typically atmospheric, to give cured materials that find applications as adhesives, sealants, potting materials for electronics, optical materials, components of light-emitting devices, silicone foams, weatherstrip coatings, and paper release coatings. These compositions comprise polyorganosiloxanes and non-silicone polymers having moisture-reactive groups, such as alkoxysilyl groups. The curing of such moisture-curable compositions is catalyzed by metal complexes, including compounds employing metals such as Sn, Ti, or Zn, and non-metal-based catalysts, such as amines, amidines, and guanidines. Organotin compounds such as for example dibutyltin dilaurate (DBTDL) are widely used as condensation cure catalysts to accelerate the moisture-assisted curing of a number of different polyorganosiloxanes and non-silicone polymers having reactive silyl groups.

The cure chemistry of these moisture-curable compositions can vary based upon the nature of the polymers and their moisture-curable groups. For example, alkoxysilyl groups first hydrolyze to give silanol functionalities, which then condense with the extrusion of water to give the siloxane network. Such compositions typically comprise an alkoxysilyl- or silanol-functional polymer and a crosslinking agent. Tri- and tetraalkoxysilanes are commonly used as crosslinking agents and will react with water or directly with silanol groups to crosslink the system. However, for compositions comprising hydridosilyl groups or both hydridosilyl and silanol functionalities, such a crosslinking agent is not required. In fact, due to the multitude of hydridosilyl groups present, the hydridosilyl-containing compound is often referred to as the crosslinking agent. In these compositions, hydridosilyl groups may react with water to give silanol functionalities or they may react directly with silanol groups to form siloxane bonds with extrusion of hydrogen gas. For transition-metal-catalyzed compositions comprising a hydridosilyl-containing compound, inhibitors are commonly used to ensure adequate shelf life or pot life.

Catalyst selection varies somewhat for these two classes of moisture-curable compositions, however, tin-based complexes, particularly DBTDL, efficiently catalyze moisture cure for both classes. Environmental regulatory agencies and directives, however, have increased or are expected to increase restrictions on the use of organotin compounds in formulated products. For example, while formulations with greater than 0.5 wt. % dibutyltin presently require labeling as toxic with reproductive 1B classification, dibutyltin-containing formulations are proposed to be completely phased out in consumer applications during the next three to five years.

The use of alternative organotin compounds such as dioctyltin compounds and dimethyltin compounds can only be considered as a short-term remedial plan, as these organotin compounds may also be regulated in the future. It would be beneficial to identify non-tin-based accelerators that accelerate the condensation curing of moisture-curable silicones and non-silicones.

Substitutes for organotin catalysts should exhibit properties similar to organotin compounds in terms of curing, storage, and appearance. Non-tin accelerators would also desirably initiate the condensation reaction of the selected polymers and complete this reaction upon the surface and may be in the bulk in a desired time schedule. There are therefore many proposals for the replacement of organometallic tin compounds with other metal- and non-metal-based compounds. These new accelerators have specific advantages and disadvantages in view of replacing tin compounds perfectly. Therefore, there is still a need to address the weaknesses of possible non-tin compounds as suitable accelerators for condensation cure reactions. The physical properties of uncured and cured compositions also warrant examination, in particular to maintain the ability to adhere onto the surface of several substrates.

SUMMARY

The present invention provides tin-free, curable compositions comprising polymers with reactive silyl groups and a non-toxic condensation accelerator based on amino acid compounds. In one embodiment, the present invention provides curable compositions employing an amino acid compound as a condensation accelerator where the amino acid compound is an N-substituted amino acid comprising at least one group other than hydrogen attached to the N-terminus. In another embodiment, the present invention provides curable compositions employing an amino acid compound as a condensation accelerator where the amino acid compound is an O-substituted amino acid comprising a group other than hydrogen attached to the O-terminus.

In one aspect, the amino acid compounds are of the Formula (6):

wherein Q is selected from

an aliphatic heterocyclic compound containing at least one nitrogen atom of the formula:

where t is an integer from 1 to 6; or an aromatic heterocyclic compound containing at least one nitrogen atom; where R⁹, R¹⁰, and R¹¹ are independently selected from hydrogen, a linear or branched alkyl, a linear or branched heteroalkyl, an aryl, a heteroaryl, a cycloalkyl, a heterocycloalkyl, a linear or branched aralkyl, or a linear or branched heteroaralkyl, a silyl group, a siloxy group, or a combination of two or more thereof; R¹² and R¹³ are independently selected from hydrogen, a linear or branched alkyl, a cycloalkyl, an aryl, a heteroaryl, a linear or branched aralkyl, a linear or branched heteroaralkyl, a silyl group, a siloxy group, a functional group of the formula,

and a functional group of the formula

where X is either O or S; and R¹⁴ and R¹⁵ are independently selected from hydrogen, a linear or branched alkyl, a cycloalkyl, an aryl, a heteroaryl, a linear or branched aralkyl, a linear or branched heteroaralkyl, OR¹⁶, N(R¹⁶)₂, or SR¹⁶; and R¹⁶ is chosen from hydrogen, a linear or branched alkyl, a cycloalkyl, an aryl, a heteroaryl, a linear or branched aralkyl, a linear or branched heteroaralkyl, an acyl group, a thioacyl group, or a combination of two or more thereof, and R¹⁶ groups may be similar or different.

In one aspect, the invention provides a curable composition exhibiting a relatively short tack-free time, curing through the bulk, as well as long storage stability in the cartridge, i.e., in the absence of humidity. Amino acid compounds, including compounds of formula (6), have been unexpectedly found to exhibit curing behavior similar to or even better than organotin compounds, and, therefore, can be suitable as replacements for organotin accelerators in compositions having polymers with reactive, silyl groups that can undergo condensation reactions, such as in RTV-1 and RTV-2 formulations.

Curable compositions using amino acid compounds may also exhibit certain storage stability of the uncured composition in the cartridge, adhesion onto several surfaces, and a cure rate in a predictable time scheme.

In one aspect, the present invention provides a composition for forming a cured polymer composition comprising: (A) a polymer having at least one reactive silyl group; (B) a crosslinker or chain extender chosen from an alkoxysilane, an alkoxysiloxane, an oximosilane, an oximosiloxane, an enoxysilane, an enoxysiloxane, an aminosilane, an aminosiloxane, a carboxysilane, a carboxysiloxane, an alkylamidosilane, an alkylamidosiloxane, an arylamidosilane, an arylamidosiloxane, an alkoxyaminosilane, an alkoxyaminosiloxane, an alkoxycarbamatosilane, an alkoxycarbamatosiloxane, and combinations of two or more thereof; (C) a catalyst chosen from an amino acid compound; (D) optionally at least one adhesion promoter chosen from a silane or siloxane other than the compounds listed under (B); (E), optionally, a filler component; and (F) optionally at least one acidic compound chosen from a phosphate ester, a phosphonate ester, a phosphonic acid, a phosphorous acid, a phosphite, a phosphonite ester, a sulfate, a sulfite, a pseudohalogenide, a branched C₄-C₂₅ alkyl carboxylic acid, or a combination of two or more thereof.

In one embodiment, the present invention provides a curable composition comprising amino acid compounds that are substantially free of tin.

In one embodiment, the polymer (A) has the formula: [R¹ _(a)R² _(3-a)Si—Z—]_(n)—X—Z—SiR¹ _(a)R² _(3-a). In another embodiment, X is chosen from a polyurethane; a polyester; a polyether; a polycarbonate; a polyolefin; a polyesterether; and a polyorganosiloxane having units of R₃SiO_(1/2), R₂SiO, RSiO_(3/2), and/or SiO₂, n is 0 to 100, a is 0 to 2, R, R¹, and R² can be identical or different at the same silicon atom and chosen from C₁-C₁₀ alkyl; C₁-C₁₀ alkyl substituted with one or more of Cl, F, N, O, or S; a phenyl; C₇-C₁₆ alkylaryl; C₇-C₁₆ arylalkyl; C₂-C₂-polyalkylene ether; or a combination of two or more thereof. In yet another aspect, R² is chosen from OH, C₁-C₈alkoxy, C₂-C₁₈ alkoxyalkyl, alkoxyaryl, oximoalkyl, oximoaryl, enoxyalkyl, enoxyaryl, aminoalkyl, aminoaryl, carboxyalkyl, carboxyaryl, amidoalkyl, amidoaryl, carbamatoalkyl, carbamatoaryl, or a combination of two or more thereof, and Z is a bond, a divalent unit selected from the group of a C₁-C₁₄ alkylene, or O.

According to one embodiment, the crosslinker component (B) is chosen from tetraethylorthosilicate (TEOS); methyltrimethoxysilane (MTMS); vinyltrimethoxysilane; methylvinyldimethoxysilane; dimethyldimethoxysilane; dimethyldiethoxysilane; vinyltriethoxysilane; tetra-n-propylorthosilicate; tris(methylethylketoximo)vinylsilane; tris(methylethylketoximo)methylsilane; tris(acetamido)methylsilane; bis(acetamido)dimethylsilane; tris(N-methylacetamido)methylsilane; bis(N-methylacetamido)dimethylsilane; (N-methylacetamido) methyldialkoxysilane; tris(benzamido)methylsilane; tris(propenoxy) methylsilane; alkyldialkoxyamidosilanes; alkylalkoxybisamidosilanes; methylethoxybis(N-methylbenzamido)silane; methylethoxydibenzamidosilane; methyldimethoxy(ethylmethylketoximo) silane; bis(ethylmethylketoximo)methylmethoxysilane; (acetaldoximo) methyldimethoxysilane; (N-methylcarbamato)methyldimethoxysilane; (N-methylcarbamato) ethyldimethoxy silane; (isopropenoxy) methyldimethoxysilane; (isopropenoxy)trimethoxysilane; tris(isopropenoxy)methylsilane; (but-2-en-2-oxy)methyldimethoxysilane; (1-phenylethenoxy)methyldimethoxysilane; 2-((1-carboethoxy)propenoxy) methyldimethoxysilane; bis(N-methylamino)methylmethoxysilane; (N-methylamino)vinyldimethoxysilane; tetrakis(N,N-diethylamino)silane; methyldimethoxy(N-methylamino)silane; methyltris(cyclohexylamino)silane; methyldimethoxy(N-ethylamino) silane; dimethylbis(N,N-dimethylamino) silane; methyldimethoxy(N-isopropylamino) silane dimethylbis(N,N-diethylamino) silane; ethyldimethoxy(N-ethylpropionamido)silane; methyldimethoxy(N-methylacetamido) silane; methyltris(N-methylacetamido)silane; ethyldimethoxy(N-methylacetamido) silane; methyltris(N-methylbenzamido) silane; methylmethoxybis(N-methylacetamido) silane; methyldimethoxy(ε-caprolactamo) silane; trimethoxy(N-methylacetamido) silane; methyldimethoxy(O-ethylacetimidato) silane; methyldimethoxy(O-propylacetimidato) silane; methyldimethoxy(N,N′,N′-trimethylureido) silane; methyldimethoxy(N-allyl-N′,N′-dimethylureido) silane; methyldimethoxy(N-phenyl-N′,N′-dimethylureido)silane; methyldimethoxy(isocyanato) silane; dimethoxydiisocyanatosilane; methyldimethoxy-isothiocyanatosilane; methylmethoxydiisothiocyanatosilane; methyltriacetoxysilane; methylmethoxydiacetoxysilane; methylethoxydiacetoxysilane; methylisopropoxydiacetoxysilane; methyl(n-propoxy) diacetoxysilane; methyldimethoxyacetoxysilane; methyldiethoxyacetoxysilane; methyldiisopropoxyacetoxysilane; methyldi(n-propoxy)acetoxysilane; or the condensates thereof; or a combination of two or more thereof.

According to one embodiment, the adhesion promoter component (D) is chosen from an (aminoalkyl)trialkoxysilane, an (aminoalkyl)alkyldialkoxysilane, a bis(trialkoxysilylalkyl)amine, a tris(trialkoxysilylalkyl)amine, a tris(trialkoxysilylalkyl)cyanuarate, a tris(trialkoxysilylalkyl)isocyanurate, an (epoxyalkyl)trialkoxysilane, an (epoxyalkylether)trialkoxysilane, or a combination of two or more thereof.

According to one embodiment, the component (F) is chosen from a phosphate ester of the formula: (R³O)PO(OH)₂; a phosphite ester of the formula (R³O)P(OH)₂; or a phosphonic acid of the formula: R³P(O)(OH)₂. In another aspect, R³ is a C₁-C₁₈ alkyl, a C₂-C₂₀ alkoxyalkyl, phenyl, a C₇-C₁₂ alkylaryl, a C₂-C₄ polyalkylene oxide ester or its mixtures with diesters; a branched C₄-C₁₄ alkyl carboxylic acid; or a combination of two or more thereof.

According to one embodiment, the composition comprises about 1 to about 10 wt. % of the crosslinker component (B) based on 100 wt. % of the polymer component (A).

According to one embodiment, the crosslinker component (B) is chosen from a silane or a siloxane, the silane or siloxane having two or more reactive groups that can undergo hydrolysis and/or condensation reaction with polymer (A) or on its own in the presence of water and component (F).

According to one embodiment, the polymer component (A) is chosen from a polyorganosiloxane comprising divalent units of the formula [R₂SiO] in the backbone, wherein R is chosen from C₁-C₁₀alkyl; C₁-C₁₀alkyl substituted with one or more of Cl, F, N, O, or S; phenyl; C₇-C₁₆ alkylaryl; C₇-C₁₆ arylalkyl; C₂-C₂₀ polyalkylene ether; or a combination of two or more thereof.

According to one embodiment, the condensation accelerator (C) is present in an amount of from about 0.1 to about 7 wt. pt. per 100 wt. pt. of component (A).

According to one embodiment, the component (F) is present in an amount of from about 0.02 to about 7 wt. pt. per 100 wt. pt. of component (A).

According to one embodiment, the polymer component (A) has the formula:

R² _(3-a)R¹ _(a)Si—Z—[R₂SiO]_(x)—[R¹ ₂SiO]_(y)—Z—SiR¹ _(a)R² _(3-a)

whereby x is 0 to 10000; y is 0 to 1000; a is 0 to 2; R is methyl. In another aspect, R¹ is chosen from a C₁-C₁₀ alkyl; a C₁-C₁₀alkyl substituted with one or more of Cl, F, N, O, or S; a phenyl; a C₇-C₁₆ alkylaryl; a C₇-C₁₆ arylalkyl; a C₂-C₂₀ polyalkylene ether; or a combination of two or more thereof, and other siloxane units may be present in amounts less than 10 mol. % preferably methyl, vinyl, phenyl. In yet another embodiment, R² is chosen from OH, a C₁-C₅alkoxy, a C₂-C₁₈ alkoxyalkyl, an oximoalkyl, an enoxyalkyl, an aminoalkyl, a carboxyalkyl, an amidoalkyl, an amidoaryl, a carbamatoalkyl, or a combination of two or more thereof, and Z is —O—, a bond, or —C₂H₄—.

According to one embodiment, the composition further comprises a solvent chosen from an alkylbenzene, a trialkylphosphate, a triarylphosphate, a phthalic acid ester, an arylsulfonic acid ester having a viscosity-density constant (VDC) of at least 0.86 that is miscible with a polyorganosiloxane and accelerator component (B), a polyorganosiloxane devoid of reactive groups and having a viscosity of less than 2000 mPa·s at 25° C., or a combination of two or more thereof.

According to one embodiment, the composition is provided as a one-part composition.

According to one embodiment, the composition comprises 100 pt. wt. of component (A), 0.1 to about 10 pt. wt. of at least one crosslinker (B), 0.01 to about 7 pt. wt. of an accelerator (C), 0.1 to about 5 pt. wt. of an adhesion promoter (D), 0 to about 300 pt. wt. of component (E), 0.01 to about 8 pt. wt. of component (F) whereby this composition can be stored in the absence of humidity and is curable in the presence of humidity upon exposure to ambient air.

According to one embodiment, the composition is a two-part composition comprising: (i) a first portion comprising the polymer component (A), optionally the filler component (E), and optionally the acidic compound (F); and (ii) a second portion comprising the crosslinker (B), the accelerator component (C), the adhesion promoter (D), and the acidic compound (F), whereby (i) and (ii) are stored separately until applied for curing by mixing of the components (i) and (ii).

According to one embodiment, portion (i) comprises 100 wt. % of component (A), and 0 to 70 pt. wt. of component (E); and portion (ii) comprises 0.1 to 10 pt. wt. of at least one crosslinker (B), 0.01 to 7 pt. wt. of an accelerator (C), 0 to 5 pt. wt. of an adhesion promoter (D), and 0.02 to 3 pt. wt. component (F).

In another aspect, the present invention provides, a composition for forming a cured polymer composition comprising (A) a polymer having at least a reactive silyl group, where the polymer is free of siloxane bonds; (B) a crosslinker or chain extender chosen from an alkoxysilane, an alkoxysiloxane, an oximosilane, an oximosiloxane, an enoxysilane, an enoxysiloxane, an aminosilane, an aminosiloxane, a carboxysilane, a carboxysiloxane, an alkylamidosilane, an alkylamidosiloxane, an arylamidosilane, an arylamidosiloxane, an alkoxyaminosilane, an alklarylaminosiloxane, an alkoxycarbamatosilane, an alkoxycarbamatosiloxane, the condensates thereof, and combinations of two or more thereof; and (C) a condensation accelerator comprising an amino acid.

In another aspect, the present invention provides a composition for forming a cured polymer composition comprising (A) a compound having at least one hydridosilyl group, and (C) a condensation cure accelerator comprising an amino acid based compound.

DETAILED DESCRIPTION

The present invention provides a curable composition employing an amino acid compound as a condensation accelerator. Amino acid compounds have been found to exhibit similar or superior curing properties as compared to compositions employing organotin compounds, such as DBTDL, in terms of accelerating moisture-assisted condensation curing of silicones to result in crosslinked silicones that can be used as sealants and RTVs (Room-Temperature Vulcanized Rubber), silicone foams, or as silicone release coatings. Further, the amino acid compounds also exhibit improved storage stability.

As used herein, “alkyl” includes straight, branched and cyclic alkyl groups. Specific and non-limiting examples of alkyls include, but are not limited to, methyl, ethyl, propyl, isobutyl, ethyl-hexyl, etc.

As used herein, “substituted alkyl” includes an alkyl group that contains one or more substituent groups that are inert under the process conditions to which the compound containing these groups is subjected. The substituent groups also do not substantially interfere with the process. As used herein, unsubstituted means the particular moiety carries hydrogen atoms on its constituent atoms, e.g. CH₃ for unsubstituted methyl. Substituted means that the group can carry typical functional groups known in organic chemistry.

As used herein, “aryl” includes a non-limiting group of any aromatic hydrocarbon from which one hydrogen atom has been removed. An aryl may have one or more aromatic rings, which may be fused, connected by single bonds or other groups. Specific and non-limiting examples of aryls include, but are not limited to, tolyl, xylyl, phenyl, naphthalenyl, etc.

As used herein, “substituted aryl” includes an aromatic group substituted as set forth in the above definition of “substituted alkyl.” Similar to an aryl, a substituted aryl may have one or more aromatic rings, which may be fused, connected by single bonds or other groups; however, when the substituted aryl has a heteroaromatic ring, the free valence in the substituted aryl group can be a heteroatom (such as nitrogen) of the heteroaromatic ring instead of a carbon. In one embodiment, substituted aryl groups herein contain 1 to about 30 carbon atoms.

As used herein, “aralkyl” include an alkyl group substituted by aryl groups.

The term “cycloalkyl” refers to a saturated or partially saturated, monocyclic, fused polycyclic, or spiro polycyclic carbocycle.

As used herein, “hetero” compounds such as “heteroalkyl,” “heteroaryl,” etc. include compounds comprising a hetero atom such as O, N, P, S, etc.

In one embodiment, the present invention provides a curable composition comprising a polymer component (A) comprising a reactive silyl group; a crosslinker component (B); an accelerator component (C) comprising an amino acid compound; optionally an adhesion promoter component (D); an optional filler component (E); optionally an acidic compound (F), and optionally auxiliary components (G).

In another embodiment, the present invention provides a curable composition comprising a polymer component (A) comprising a hydridosilyl group; an accelerator component (C) comprising an amino acid compound; and optionally auxiliary components (G).

The polymer component (A) may be a liquid- or solid-based polymer having a reactive silyl group. The polymer component (A) is not particularly limited and may be chosen from any crosslinkable polymer as may be desired for a particular purpose or intended use. Non-limiting examples of suitable polymers for the polymer component (A) include polyorganosiloxanes (A1) or organic polymers free of siloxane bonds (A2), wherein the polymers (A1) and (A2) comprise reactive silyl groups. In one embodiment, the polymer component (A) may be present in an amount of from about 10 to about 90 wt. % of the curable composition. In one embodiment, the curable composition comprises about 100 pt. wt. of the polymer component (A).

As described above, the polymer component (A) may include a wide range of polyorganosiloxanes. In one embodiment, the polymer component may comprise one or more polysiloxanes and copolymers of formula (1):

[R¹ _(c)R² _(3-c)Si—Z—]_(n)—X—Z—SiR¹ _(c)R² _(3-c)  (1)

R¹ may be chosen from linear or branched alkyl, linear or branched heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, linear or branched aralkyl, linear or branched heteroaralkyl, or a combination of two or more thereof. In one embodiment, R¹ may be chosen from C₁-C₁₀ alkyl; C₁-C₁₀ alkyl substituted with one or more of Cl, F, N, O, or S; phenyl; C₇-C₁₆ alkylaryl; C₇-C₁₆ arylalkyl; C₂-C₂₀ polyalkylene ether; or a combination of two or more thereof. Exemplary preferred groups are methyl, trifluoropropyl, and/or phenyl groups.

R² may be a group reactive to protic agents such as water. Exemplary groups for R² include OH, alkoxy, alkenyloxy, alkyloximo, alkylcarboxy, arylcarboxy, alkylamido, arylamido, or a combination of two or more thereof. In one embodiment, R² is chosen from OH, C₁-C₈ alkoxy, C₂-C₁₈ alkoxyalkyl, amino, alkenyloxy, alkyloximo, alkylamino, arylamino, alkylcarboxy, arylcarboxy, alkylamido, arylamido, alkylcarbamato, arylcarbamato, or a combination of two or more thereof.

Z may be a bond, a divalent linking unit selected from the group of O, hydrocarbons which can contain one or more O, S, or N atom, amide, urethane, ether, ester, urea units or a combination of two or more thereof. If the linking group Z is a hydrocarbon group, then Z is linked to the silicon atom over a silicon-carbon bond. In one embodiment, Z is chosen from a C₁-C₁₄ alkylene.

X is chosen from a polyurethane; a polyester; a polyether; a polycarbonate; a polyolefin; a polyesterether; and a polyorganosiloxane having units of R¹ ₃SiO_(1/2), R¹ ₂SiO, R¹SiO_(3/2), and/or SiO₂, where R¹ is defined as above. X may be a divalent or multivalent polymer unit selected from the group of siloxy units linked over oxygen or hydrocarbon groups to the silyl group comprising the reactive group R² as described above, polyether, alkylene, isoalkylene, polyester, or polyurethane units linked over hydrocarbon groups to the silicon atom comprising one or more reactive groups R² as described above. The hydrocarbon group X can contain one or more heteroatoms such as N, S, O, or P forming amides, esters, ethers, urethanes, esters, and/or ureas. In one embodiment, the average polymerization degree (P_(n)) of X should be more than 6, e.g. polyorganosiloxane units of R¹ ₃SiO_(1/2), R¹ ₂SiO, R¹SiO_(3/2), and/or SiO₂. In formula (1), n is 0 to 100; desirably 1, and c is 0 to 2, desirably 0 to 1.

Non-limiting examples of the components for unit X include polyoxyalkylene polymers such as polyoxyethylene, polyoxypropylene, polyoxybutylene, polyoxyethylene-polyoxypropylene copolymer, polyoxytetramethylene, or polyoxypropylene-polyoxybutylene copolymer; ethylene-propylene copolymer, polyisobutylene, polychloroprene, polyisoprene, polybutadiene, copolymer of isobutylene and isoprene, copolymers of isoprene or butadiene and acrylonitrile and/or styrene, or hydrocarbon polymers such as hydrogenated polyolefin polymers produced by hydrogenating these polyolefin polymers; polyester polymer manufactured by a condensation of dibasic acid such as adipic acid or phthalic acid and glycol, or ring-opening polymerization of lactones; polyacrylic acid ester produced by radical polymerization of a monomer such as C₂-C₈-alkyl acrylates, vinyl polymers, e.g., acrylic acid ester copolymer of acrylic acid ester such as ethyl acrylate or butyl acrylate and vinyl acetate, acrylonitrile, methyl methacrylate, acrylamide, or styrene; graft polymer produced by polymerizing the above organic polymer with a vinyl monomer; polycarbonates; polysulfide polymer; polyamide polymer such as Nylon 6 produced by ring-opening polymerization of ε-caprolactam, Nylon 6-6 produced by polycondensation of hexamethylenediamine and adipic acid, etc., Nylon 12 produced by ring-opening polymerization of ε-laurolactam, copolymeric polyamides, polyurethanes, or polyureas.

Particularly suitable polymers include, but are not limited to, polysiloxanes, polyoxyalkylenes, saturated hydrocarbon polymers such as polyisobutylene, hydrogenated polybutadiene and hydrogenated polyisoprene, or polyethylene, polypropylene, polyesters, polycarbonates, polyurethanes, polyurea polymers and the like. Furthermore, saturated hydrocarbon polymer, polyoxyalkylene polymer, and vinyl copolymer are particularly suitable due to their low glass transition temperature which provide a high flexibility at low temperatures, i.e., below 0° C.

The reactive silyl groups in formula (1) can be introduced by employing silanes containing a functional group which has the ability to react by known methods with unsaturated hydrocarbons via hydrosilylation, or reaction of SiOH, aminoalkyl or -aryl, HOOC-alkyl or -aryl, HO-alkyl or -aryl, HS-alkyl or -aryl, Cl(O)C-alkyl or -aryl, epoxyalkyl or epoxycycloalkyl groups in the prepolymer to be linked to a reactive silyl group via condensation or ring-opening reactions. Examples of the main embodiments include the following: (i) siloxane prepolymers having a SiOH group that can undergo a condensation reaction with a silane (LG)SiR¹ _(c)R² _(3-c) whereby a siloxy bond —Si—O—SiR¹ _(c)R² _(3-c) is formed while the addition product of the leaving group (LG) and hydrogen is released (LG-H); (ii) silanes having an unsaturated group that is capable of reacting via hydrosilylation or radical reaction with a SiH group or radically activated groups of a silane such as SiH or an unsaturated group; and (iii) silanes including organic or inorganic prepolymers having OH, SH, amino, epoxy, —COCl, —COOH groups, which can react complementarily with epoxy, isocyanato, OH, SH, cyanato, carboxylic halogenides, reactive alkylhalogenides, lactones, lactams, or amines, that is to link the reactive prepolymer with the organofunctional silanes to yield a silyl functional polymer.

Silanes suitable for method (i) include alkoxysilanes, especially tetraalkoxysilanes, di- and trialkoxysilanes, di- and triacetoxysilanes, di- and triketoximosilanes, di- and trialkenyloxysilanes, di- and tricarbonamidosilanes, wherein the remaining residues at the silicon atom of the silane are substituted or unsubstituted hydrocarbons. Other non-limiting silanes for method (i) include alkyltrialkoxysilanes, such as vinyltrimethoxysilane, methyltrimethoxysilane, propyltrimethoxysilane, aminoalkyltrimethoxysilane, ethyltriacetoxysilane, methyl- or propyltriacetoxysilane, methyltributanonoximosilane, methyltripropenyloxysilane, methyltribenzamidosilane, or methyltriacetamidosilane. Prepolymers suitable for reaction under method (i) are SiOH-terminated polyalkylsiloxanes, which can undergo a condensation reaction with a silane having hydrolyzable groups attached to the silicon atom. Exemplary SiOH-terminated polyalkyldisiloxanes include polydimethylsiloxanes.

Suitable silanes for method (ii) include alkoxysilanes, especially trialkoxysilanes (HSi(OR)₃) such as trimethoxysilane, triethoxysilane, methyldiethoxysilane, methyldimethoxysilane, and phenyldimethoxysilane. Hydrogenchlorosilanes are in principle possible but are less desirable due to the additional replacement of the halogen through an alkoxy, acetoxy group, etc. Other suitable silanes include organofunctional silanes having unsaturated groups which can be activated by radicals, such as vinyl, allyl, mercaptoalkyl, or acrylic groups. Non-limiting examples include vinyltrimethoxysilane, mercaptopropyltrimethoxysilane, and methacryloxypropyltrimethoxysilane. Prepolymers suitable for reaction under method (ii) include vinyl-terminated polyalkylsiloxanes, preferably polydimethylsiloxanes, hydrocarbons with unsaturated groups which can undergo hydrosilylation or can undergo radically induced grafting reactions with a corresponding organofunctional group of a silane comprising, for example, unsaturated hydrocarbon or a SiH group.

Another method for introducing silyl groups into hydrocarbon polymers can be the copolymerization of unsaturated hydrocarbon monomers with the unsaturated groups of silanes. The introduction of unsaturated groups into a hydrocarbon prepolymer may include, for example, the use of alkenyl halogenides as chain stopper after polymerization of the silicon free hydrocarbon moiety.

Desirable reaction products between the silanes and prepolymers include the following structures: —SiR¹ ₂O—SiR¹ ₂—CH₂—CH₂—SiR¹ _(c)R² _(3-c), or (hydrocarbon)-[Z—SiR¹ _(c)R² _(3-c)]_(n). Suitable silanes for method (iii) include, but are not limited to, alkoxysilanes, especially silanes having organofunctional groups to be reactive to —OH, —SH, amino, epoxy, —COCl, or —COOH.

In one embodiment, these silanes have an isocyanatoalkyl group such as gamma-isocyanatopropyltrimethoxysilane, gamma-isocyanatopropylmethyldimethoxysilane, gamma-isocyanatopropyltriethoxysilane, gamma-glycidoxypropylethyldimethoxysilane, gamma-glycidoxypropyltrimethoxysilane, gamma-glycidoxypropyltriethoxysilane, beta-(3, 4-epoxycyclohexyl) ethyltrimethoxysilane, beta-(3, 4-epoxycyclohexyl) ethyltriethoxysilane, epoxylimonyltrimethoxysilane, N-(2-aminoethyl)-aminopropyltrimethoxysilane, gamma-aminopropyltriethoxysilane, gamma-aminopropyltrimethoxysilane, gamma-aminopropylmethyldimethoxysilane, gamma-aminopropylmethyldiethoxysilane, etc.

In one embodiment, it is desirable to select either blocked amines or isocyanates (Z′—X)_(n)—Z′ for carrying out first a complete mixing and then the following coupling reaction. Examples of blocking agents are disclosed in EP 0947531 and other blocking procedures that employ heterocyclic nitrogen compounds such as caprolactam or butanone oxime, or cyclic ketones referred to in U.S. Pat. No. 6,827,875 both of which are incorporated herein by reference in their entirety.

Examples of suitable prepolymers for a reaction under method (iii) include, but are not limited to, polyalkylene oxides having OH groups, preferably with a high molecular weight (M_(w), weight-average molecular weight >6000 g/mol) and a polydispersity M_(w)/M_(n) of less than 1.6; urethanes having remaining NCO groups, such as NCO functionalized polyalkylene oxides, especially blocked isocyanates. Prepolymers selected from the group of hydrocarbons having —OH, —COOH, amino, epoxy groups, which can react complementarily with an epoxy, isocyanato, amino, carboxyhalogenide or halogenalkyl group of the corresponding silane having further reactive groups useful for the final cure.

Suitable isocyanates for the introduction of a NCO group into a polyether may include toluene diisocyanate, diphenylmethane diisocyanate, or xylene diisocyanate, or aliphatic polyisocyanate such as isophorone diisocyanate, or hexamethylene diisocyanate.

The polymerization degree of the unit X depends on the requirements of viscosity and mechanical properties of the cured product. If X is a polydimethylsiloxane unit, the average polymerization degree based on the number average molecular weight Mn is preferably 7 to 5000 siloxy units, preferably 200 to 2000 units. In order to achieve a sufficient tensile strength of >5 MPa, an average polymerization degree Pn of >250 is suitable whereby the polydimethylsiloxanes have a viscosity of more than 300 mPa·s at 25° C. If X is a hydrocarbon unit other than a polysiloxane unit, the viscosity with respect to the polymerization degree is much higher.

Examples of the method for synthesizing a polyoxyalkylene polymer include, but are not limited to, a polymerization method using an alkali catalyst such as KOH, a polymerization method using a metal-porphyrin complex catalyst such as a complex obtained by reacting an organoaluminum compound, a polymerization method using a composite metal cyanide complex catalyst disclosed, e.g., in U.S. Pat. Nos. 3,427,256; 3,427,334; 3,278,457; 3,278,458; 3,278,459; 3,427,335; 6,696,383; and 6,919,293.

If the group X is selected from hydrocarbon polymers, then polymers or copolymers having isobutylene units are particularly desirable due to its physical properties such as excellent weatherability, excellent heat resistance, and low gas and moisture permeability.

Examples of the monomers include olefins having 4 to 12 carbon atoms, vinyl ether, aromatic vinyl compound, vinylsilanes, and allylsilanes.

Examples of the copolymer component include 1-butene, 2-butene, 2-methyl-1-butene, 3-methyl-1-butene, pentene, 4-methyl-1-pentene, hexene, vinylcyclohexene, methyl vinyl ether, ethyl vinyl ether, isobutyl vinyl ether, styrene, alpha-methylstyrene, dimethylstyrene, beta-pinene, indene, and for example, but not limited to, vinyltrialkoxysilanes, e.g. vinyltrimethoxysilane, vinylmethyldichlorosilane, vinyldimethylmethoxysilane, divinyldichlorosilane, divinyldimethoxysilane, allyltrichlorosilane, allylmethyldichlorosilane, allyldimethylmethoxysilane, diallyldichlorosilane, diallyldimethoxysilane, gamma-methacryloyloxypropyltrimethoxysilane, and gamma-methacryloyloxypropylmethyldimethoxysilane.

Examples of suitable siloxane-free organic polymers include, but are not limited to, silylated polyurethane (SPUR), silylated polyester, silylated polyether, silylated polycarbonate, silylated polyolefins like polyethylene, polypropylene, silylated polyesterether and combinations of two or more thereof. The siloxane-free organic polymer may be present in an amount of from about 10 to about 90 wt. % of the composition or about 100 pt. wt.

In one embodiment, the polymer component (A) may be silylated polyurethane (SPUR). Such moisture curable compounds are known in the art in general and can be obtained by various methods including (i) reacting an isocyanate-terminated polyurethane (PUR) prepolymer with a suitable silane, e.g., one possessing both hydrolyzable functionality at the silicon atom, such as, alkoxy, etc., and secondly active hydrogen-containing functionality such as mercaptan, primary or secondary amine, preferably the latter, etc., or by (ii) reacting a hydroxyl-terminated PUR (polyurethane) prepolymer with a suitable isocyanate-terminated silane, e.g., one possessing one to three alkoxy groups.

The details of these reactions, and those for preparing the isocyanate-terminated and hydroxyl-terminated PUR prepolymers employed therein can be found in, amongst others: U.S. Pat. Nos. 4,985,491; 5,919,888; 6,207,794; 6,303,731; 6,359,101; and 6,515,164, and published U.S. Patent Publication Nos. 2004/0122253 and US 2005/0020706 (isocyanate-terminated PUR prepolymers); U.S. Pat. Nos. 3,786,081 and 4,481,367 (hydroxyl-terminated PUR prepolymers); U.S. Pat. Nos. 3,627,722; 3,632,557; 3,971,751; 5,623,044; 5,852,137; 6,197,912; and 6,310,170 (moisture-curable SPUR (silane modified/terminated polyurethane) obtained from reaction of isocyanate-terminated PUR prepolymer and reactive silane, e.g., aminoalkoxysilane); and, U.S. Pat. Nos. 4,345,053; 4,625,012; 6,833,423; and published U.S. Patent Publication 2002/0198352 (moisture-curable SPUR obtained from reaction of hydroxyl-terminated PUR prepolymer and isocyanatosilane). The entire contents of the foregoing U.S. patent documents are incorporated by reference herein. Other examples of moisture-curable SPUR materials include those described in U.S. Pat. No. 7,569,653, the disclosure of which is incorporated by reference in its entirety.

In one embodiment, the polymer component (A) may be a polymer of formula (2):

R² _(3-c)R¹ _(c)Si—Z—[R₂SiO]_(x)[R¹ ₂SiO]_(y)—Z—SiR¹ _(c)R² _(3-c)(2)

where R¹, R², Z, and c are defined as above with respect to formula (1); R is C₁-C₆ alkyl (an exemplary alkyl being methyl); x is 0 to about 10,000, in one embodiment from 11 to about 2500; and y is 0 to about 10,000; preferably 0 to 500. In one embodiment, Z in a compound of formula (2) is a bond or a divalent C₁-C₁₄ alkylene group, especially preferred is —C₂H₄—.

In one embodiment, the polymer component (A) may be a polyorganosiloxane of the formula (3):

R² _(3-c-d)SiR³ _(c)R⁴ _(d)—[OSiR³R⁴]_(x)—[OSiR³R⁴]_(y)—OSiR³ _(e)R⁴ _(f)R² _(3-e-f)  (3)

where R², c, x, and y are defined as above with respect to formula (1); where R³ and R⁴ can be identical or different on the same silicon atom and are chosen from hydrogen; C₁-C₁₀alkyl; C₁-C₁₀ heteroalkyl, C₃-C₁₂ cycloalkyl; C₂-C₃₀ heterocycloalkyl; C₆-C₁₃ aryl; C₇-C₃₀ alkylaryl; C₇-C₃₀ arylalkyl; C₄-C₁₂ heteroaryl; C₅-C₃₀ heteroarylalkyl; C₅-C₃₀ heteroalkylaryl; C₂-C₁₀₀ polyalkylene ether; or a combination of two or more thereof. Where d is 0, 1, or 2; e is 0, 1, or 2; and f is 0, 1, or 2.

Non-limiting examples of suitable polysiloxane-containing polymers (A1) include, for example, silanol-stopped polydimethylsiloxane, silanol or alkoxy-stopped polyorganosiloxanes, e.g., methoxystopped polydimethylsiloxane, alkoxy-stopped polydimethylsiloxane-polydiphenylsiloxane copolymer, and silanol or alkoxy-stopped fluoroalkyl-substituted siloxanes such as poly(methyl 3,3,3-trifluoropropyl)siloxane and poly(methyl 3,3,3-trifluoropropyl) siloxane-polydimethyl siloxane copolymer. The polyorganosiloxane component (A1) may be present in an amount of about 10 to about 90 wt. % of the composition or 100 pt. wt. In one preferred embodiment, the polyorganosiloxane component has an average chain length in the range of about 10 to about 2500 siloxy units, and the viscosity is in the range of about 10 to about 500,000 mPa·s at 25° C.

Alternatively, the composition may include silyl-terminated organic polymers (A2) that are free of siloxane units, and which undergo curing by a condensation reaction comparable to that of siloxane containing polymers (A1). Similar to the polyorganosiloxane polymer (A1), the organic polymers (A2) that are suitable as the polymer component (A) include a reactive silyl group. In one embodiment, the reactive silyl group may be of the formula (4):

—SiR¹ _(d)R² _(3-d)  (4)

where R¹, R², and d are as defined above.

The polysiloxane composition may further include a crosslinker or a chain extender as component (B). In one embodiment, the crosslinker is of the formula (5):

R¹ _(d)SiR² _(4-d)  (5)

wherein R¹, R², and d are as defined above. Alternatively, the crosslinker component may be a condensation product of formula (5) wherein one or more but not all R² groups are hydrolyzed and released in the presence of water and then intermediate silanols undergo a condensation reaction to give a Si—O—Si bond and water. The average polymerization degree can result in a compound having 2 to 10 Si units.

In one embodiment, the crosslinker is an alkoxysilane having a formula R³ _(d)(R¹O)_(4-d)Si, wherein R¹, R³, and d are defined as above. In another embodiment, the crosslinker is an acetoxysilane having a formula (R³ _(d)(R¹CO₂)_(4-d)Si, wherein R¹, R³, and d are defined as above. In still another embodiment, the crosslinker is an oximosilane having a formula R³ _(d)(R¹R⁴C═N—O)_(4-d)Si, where R¹, R³, R⁴, and d are defined as above.

As used herein, the term crosslinker includes a compound including an additional reactive component having at least two hydrolysable groups and less than three silicon atoms per molecule not defined under (A). In one embodiment, the crosslinker or chain extender may be chosen from an alkoxysilane, an alkoxysiloxane, an oximosilane, an oximosiloxane, an enoxysilane, an enoxysiloxane, an aminosilane, an aminosiloxane, a carboxysilane, a carboxysiloxane, an alkylamidosilane, an alkylamidosiloxane, an arylamidosilane, an arylamidosiloxane, an alkoxyaminosilane, an alkylarylaminosiloxane, an alkoxycarbamatosilane, an alkoxycarbamatosiloxane, an imidatosilane, a ureidosilane, an isocyanatosilane, a isothiocyanatosilane, the condensates thereof and combinations of two or more thereof. Examples of suitable cross-linkers include, but are not limited to, tetraethylorthosilicate (TEOS); methyltrimethoxysilane (MTMS); methyltriethoxysilane; vinyltrimethoxysilane; vinyltriethoxysilane; methylphenyldimethoxysilane; 3,3,3-trifluoropropyltrimethoxysilane; methyltriacetoxysilane; vinyltriacetoxysilane; ethyltriacetoxysilane; di-butoxydiacetoxysilane; phenyltripropionoxysilane; methyltris(methylethylketoximo)silane; vinyltris(methylethylketoximo) silane; 3,3,3-trifluoropropyltris(methylethylketoximo) silane; methyltris(isopropenoxy) silane; vinyltris(isopropenoxy)silane; ethylpolysilicate; dimethyltetraacetoxydisiloxane; tetra-n-propylorthosilicate; methyldimethoxy(ethylmethylketoximo) silane; methylmethoxybis(ethylmethylketoximo) silane; methyldimethoxy(acetaldoximo)silane; methyldimethoxy(N-methylcarbamato) silane; ethyldimethoxy(N-methylcarbamato) silane; methyldimethoxyisopropenoxysilane; trimethoxyisopropenoxysilane; methyltriisopropenoxysilane; methyldimethoxy(but-2-en-2-oxy) silane; methyldimethoxy(1-phenylethenoxy) silane; methyldimethoxy-2-(1-carboethoxypropenoxy) silane; methylmethoxydi(N-methylamino) silane; vinyldimethoxy(methylamino)silane; tetra-N,N-diethylaminosilane; methyldimethoxy(methylamino)silane; methyltri(cyclohexylamino)silane; methyldimethoxy(ethylamino) silane; dimethyldi(N,N-dimethylamino) silane; methyldimethoxy(isopropylamino) silane; dimethyldi(N,N-diethylamino) silane; ethyldimethoxy(N-ethylpropionamido) silane; methyldimethoxy(N-methylacetamido) silane; methyltris(N-methylacetamido)silane; ethyldimethoxy(N-methylacetamido) silane; methyltris(N-methylbenzamido) silane; methylmethoxybis(N-methylacetamido) silane; methyldimethoxy(caprolactamo) silane; trimethoxy(N-methylacetamido) silane; methyldimethoxy(ethylacetimidato) silane; methyldimethoxy(propylacetimidato) silane; methyldimethoxy(N,N′,N′-trimethylureido) silane; methyldimethoxy(N-allyl-N′,N′-dimethylureido) silane; methyldimethoxy(N-phenyl-N′,N′-dimethylureido) silane; methyldimethoxyisocyanatosilane; dimethoxydiisocyanatosilane; methyldimethoxyisothiocyanatosilane; methylmethoxydiisothiocyanatosilane, the condensates thereof, or combinations of two or more thereof. In one embodiment, the crosslinker may be present in an amount from about 1 to about 10 wt. % of the composition or from about 0.1 to about 10 pt. wt. per 100 pt. wt. of the polymer component (A). In another embodiment, the crosslinker may be present in an amount from about 0.1 to about 5 pt. wt. per 100 pt. wt. of the polymer component (A). In still another embodiment, the crosslinker may be present in an amount from about 0.5 to about 3 pt. wt. per 100 pt. wt. of the polymer component (A). Here as elsewhere in the specification and claims, numerical values may be combined to form new or undisclosed ranges.

Additional alkoxysilanes in an amount greater than 0.1 wt. % of component (A) that are not consumed by the reaction between the prepolymer Z′—X—Z′ and which comprise additional functional groups selected from R⁵ can also work as an adhesion promoter and are defined and counted under component (D).

In one embodiment, the condensation accelerator (C) comprises an amino acid based condensation cure catalyst and/or cure accelerator. In one embodiment, the present invention provides curable compositions employing an alpha-amino acid as a cure catalyst and/or cure accelerator. In one aspect, the amino acid additives are compounds of the Formula (6):

wherein Q is selected from

an aliphatic heterocyclic compound containing at least one nitrogen atom of the formula:

where t is an integer from 1 to 6; an aromatic heterocyclic compound containing at least one nitrogen atom; where R⁹, R¹⁰, and R¹¹ are independently selected from hydrogen, a linear or branched alkyl, a linear or branched heteroalkyl, an aryl, a heteroaryl, a cycloalkyl, a heterocycloalkyl, a linear or branched aralkyl, or a linear or branched heteroaralkyl, a silyl group, a siloxy group, or a combination of two or more thereof; R¹² and R¹³ are independently selected from hydrogen, a linear or branched alkyl, a cycloalkyl, an aryl, a heteroaryl, a linear or branched aralkyl, a linear or branched heteroaralkyl, a silyl group, a siloxy group, a functional group of the formula,

or a functional group of the formula

where X is either O or S; and R¹⁴ and R¹⁵ are independently selected from hydrogen, a linear or branched alkyl, a cycloalkyl, an aryl, a heteroaryl, a linear or branched aralkyl, a linear or branched heteroaralkyl, OR¹⁶, N(R¹⁶)₂, or SR¹⁶; and R¹⁶ is chosen from hydrogen, a linear or branched alkyl, a cycloalkyl, an aryl, a heteroaryl, a linear or branched aralkyl, a linear or branched heteroaralkyl, an acyl group, a thioacyl group, or a combination of two or more thereof, and R¹⁶ groups may be similar or different.

In one embodiment, the amino acid is of the formula (7):

where R⁹-R¹³ can be as described above.

In one embodiment, R⁹, R¹², or both R⁹ and R¹² is a group other than hydrogen. In one embodiment R⁹ is a group other than hydrogen (an O-substituted amino acid). In another embodiment, R¹² is a group other than hydrogen (an N-substituted amino acid).

In one embodiment, the condensation accelerator (C) comprises an amino acid compound derived from a base amino acid that is substituted at the N-terminus with at least one group other than hydrogen. The amino acids can be derived from naturally occurring or synthetic amino acids. The naturally occurring amino acids can be in either the D or L configuration. The amino acid compounds can be derived from amino acids including, but not limited to, natural amino acids such as L-alanine, L-arginine, L-asparagine, L-aspartic acid, L-cysteine, L-glutamic acid, L-glutamine, L-glycine, L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, L-phenylalanine, L-proline, L-serine, L-threonine, L-tryptophan, L-tyrosine, L-valine, and mixtures thereof, that has been modified to include at least one substituent other than hydrogen attached to the amino terminal end. Examples of nitrogen-heterocycle-containing amino acids include but are not limited to 1-proline, 2-piperidinecarboxylic acid, azepane-2-carboxylic acid, pyrrole-2-carboxylic acid, pyridine-2-carboxylic acid, pyridine-3-carboxylic acid, pyridine-4-carboxylic acid, 3-indoleacetic acid, indole-2-carboxylic acid, 2-oxazolecarboxylic acid, thiazole-2-carboxylic acid, imidazole-2-carboxylic acid, 2-quinolinecarboxylic acid, 3-isoquinolinecarboxylic acid, 9H-carbazole-1-carboxylic acid, 1H-pyrrole-1-ylacetic acid, 2-(1H-pyrrol-1-yl)propanoic acid, 2,3-dihydro-1H-indole-2-carboxylic acid, pyroglutamic acid, 6-oxo-2-piperidinecarboxylic acid, (2,5-dioxo-1-pyrrolidinyl)acetic acid, (1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid, 1-pyrrolidinylacetic acid, and 1-piperidinylacetic acid.

The alkyl group for R⁹-R¹³ can be a (C₁-C₂₀)alkyl, a (C₁-C₁₂)alkyl, (C₁-C₈)alkyl, (C₁-C₅)alkyl, even a (C₁-C₄)alkyl. Examples of suitable alkyl groups include, but are not limited to methyl, ethyl, n-propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl, tert-pentyl, hexyl, isohexyl, etc.

The cycloalkyl group for the R⁹-R¹³ can be a cycloalkyl having from 3 to 12 ring atoms per carbocycle, and can be optionally substituted or unsubstituted. In some embodiments, an alkyl group refers to a cycloalkyl group that accordingly includes a ring structure. Examples of suitable cycloalkyl groups include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl etc.

The aryl group suitable for R⁹-R¹³ can have from 6 to 30 carbon atoms, for example, about 6-14 carbon atoms, about 6-13 carbon atoms, or about 6-10 carbon atoms. The aryl group can have a single ring (e.g., phenyl) or multiple condensed (fused) rings, wherein at least one ring is aromatic (e.g., naphthyl, dihydrophenanthrenyl, fluorenyl, or anthryl). Typical aryl groups include, but are not limited to, radicals derived from benzene, naphthalene, anthracene, biphenyl, and the like. The aryl can be unsubstituted or optionally substituted. In one embodiment, the aryl can be phenyl, indenyl, 5,6,7,8-tetrahydronaphthyl, naphthyl etc.

In one embodiment, the R¹² and R¹³ groups can be chosen from a (C₁-C₆)alkanoyl including, but not limited to, acetyl, propanoyl, butanoyl, etc.

In one embodiment, the amino acid is a N-acetyl amino acid. Examples of suitable N-acetyl amino acids include, but are not limited to, N-acetyl-glycine, N-acetyl-alanine, N-acetyl-valine, N-acetyl-leucine, N-acetyl-isoleucine, N-acetyl-serine, N-acetyl-threonine, N-acetyl-cysteine, N-acetyl-methionine, N-acetyl-aspartic acid, N-acetyl-asparagine, N-acetyl-glutamic acid, N-acetyl-giutamine, N-acetyl-arginine, N-acetyl-lysine, N-acetyl-histidine, N-acetyl-phenylalanine, N-acetyl-tyrosine, N-acetyl-tryptophan, N-acetyl-proline, N-acetyl-taurine, N-acetyl-aminobutanoic acid, N-acetyl-hydroxyproline, N-acetyl-canavanine, N-acetyl-hydroxylysine, N-acetyl-cycloserine, N-acetyl-homoarginine, N-acetyl-norleucine, N-acetyl-norvaline, N-acetyl-homoserine, N-acetyl-methylserine, N-acetyl-hydroxyvaline, N-acetyl-ethionine, N-acetyl-methoxinine, N-acetyl-6-aminoisobutanoic acid, N-acetyl-homocysteine, N-acetyl-cysteine sulfinic acid, N-acetyl-homophenylalanine, N-acetyl-homotryptophan, N-acetyl-hydroxytryptamine (N-acetylserotonin), N-acetyl-tryptamine, N-acetyl-ornithine, N-acetyl-citrulline, N-acetyl-argininosuccinic acid, N-acetyl-dopa, N-acetyl-3-iodotyrosine, N-acetyl-3,5-diiodotyrosine, N-acetyl-3,5,3′-triiodothyronine, N-acetyl-thyroxine, N-acetyl-creatine, N-acetyl-creatinine, N-acetyl-cystine, N-acetyl-homocystine, etc.

The silyl group suitable for R⁹-R¹³ is of the formula:

—Si(R¹⁷)₃

wherein R¹⁷ is the same or different and is chosen from the group consisting of hydrogen, an alkoxy group, a linear or branched alkyl, a cycloalkyl, a linear or branched heteroalkyl, an aryl, a linear or branched aralkyl, an alkyl or aralkyl bridge formed by two R¹⁷ groups, or a combination of two or more thereof.

In one embodiment, the amino acid is the trialkylsilyl ester of an amino acid. Examples of suitable amino acid trialkylsilyl esters include, but are not limited to, glycine trimethylsilyl ester, alanine trimethylsilyl ester, d-alanine trimethylsilyl ester, glycine tert-butyldimethylsilyl ester, 1-serine trimethylsilyl ester, valine trimethylsilyl ester, norvaline trimethylsilyl ester, isoleucine trimethylsilyl ester, 1H-imidazole-1-acetic acid trimethylsilyl ester, 2-pyridinecarboxylic acid trimethylsilyl ester, proline trimethylsilyl ester, 2-piperidinecarboxylic acid trimethylsilyl ester, etc.

In one embodiment, the amino acid is the trialkylsilyl ester of a N-acetyl amino acid. Examples of suitable N-acetyl amino acid trialkylsilyl esters include, but are not limited to, N-(trifluoroacetyl)-1-leucine trimethylsilyl ester, etc.

In one embodiment, the amino acid is the trialkylsilyl ester of a N-trialkylsilyl amino acid. Examples of suitable N-trialkylsilyl amino acid trialkylsilyl esters include, but are not limited to, 2-methyl-(N-(trimethylsilyl)-alanine trimethylsilyl ester, S-ethyl-N-(trimethylsilyl)-homocysteine trimethylsilyl ester, 1-(trimethylsilysily)-1H-indole2-carboxylic acid trimethylsilyl ester, etc.

In one embodiment, the amino acid is the trialkylsilyl ester of a N,N-bis(trialkylsiiyi)amino acid. Suitable examples include, but are not limited to, 2-[bis(trimethylsilyl)amino]-butanoic acid trimethylsilyl ester, etc.

The siloxy group suitable for R⁹-R¹³ is of the formula:

—Si(R¹)_(r)(R^(1S))_(3-r)

wherein R¹ is defined as above; R^(1S) is the same or different and is a polyorganosiloxane having units of R¹ ₃SiO_(1/2), R¹ ₂SiO, R¹SiO_(3/2), and/or SiO₂, where R¹ is defined as above; and r is 0 to 2.

In one embodiment, the amino acid is the siloxysilyl ester of an amino acid. Suitable examples include, but are not limited to, glycine bis(trimethylsiloxy)methylsilyl ester, alanine bis(trimethylsiloxy)methylsilyl ester, valine bis(trimethylsiloxy)methylsilyl ester, leucine bis(trimethylsiloxy)methylsilyl ester, glycine dimethyl(trimethylsiloxy)silyl ester, alanine dimethyl(trimethylsiloxy) silyl ester, valine dimethyl(trimethylsiloxy)silyl ester, leucine dimethyl(trimethyl(trimethylsiloxy)silyl ester, etc.

The condensation accelerator (C) can comprise a single amino acid compound or a combination of two or more amino acid compounds. The condensation accelerator (C) can function as a reaction accelerator. It can also be considered and may function as a catalyst.

In one embodiment, the accelerator (C) is substantially free of tin. In one embodiment, the accelerator has less than 10 wt. % of tin; less than 7.5 wt. % of tin; less than 5 wt. % of tin; less than 1 wt. % of tin; less than 0.1 wt. % of tin; even less than 0.01 wt. % of tin.

The accelerator (C) can include other compounds known to accelerate or catalyze the condensation reaction such as complexes or salts of metals including, but not limited to, strontium, barium, yttrium, titanium, zirconium, hafnium, chromium, molybdenum, manganese, iron, ruthenium, cobalt, nickel, zinc, lanthanum, cerium, samarium, aluminum, indium, lead, bismuth; carboxylic acids including but not limited to acetic acid, lauric acid, stearic acid, and Versatic acid; alkyl- and arylsulfonic acids including, but not limited to, p-toluenesulfonic acid and methanesulfonic acid; inorganic acids including, but not limited to, hydrochloric acid, phosphoric acid, and boric acid; amines including, but not limited to, trioctylamine, dibutylamine, and dodecylamine; guanidines including but not limited to tetramethylguanidine; amidines including, but not limited to, 1,8-diazabicyclo[5.4.0]-7-undecene (DBU) and 1,5-diazabicyclo[4.3.0]non-5-ene (DBN); and inorganic bases including, but not limited to, lithium hydroxide and sodium methoxide; such that the system is substantially free of fluorine and tin.

In one embodiment, the condensation accelerator (C) may be added to the curable composition such that the amino acid compound(s) is present or added in an amount of from about 0.001 to about 10 pt. wt. related to 100 part per weight of component (A). In another embodiment the amino acid compound may be present in an amount of from about 0.01 to about 7.0 pt. wt. In still another embodiment, the amino acid compound may be present in an amount of from about 0.1 to about 2.5 pt. wt. In still another embodiment, the amino acid compound may be present in an amount of about 0.005 to about 7 pt. wt.; about 0.05 to about 5 pt. wt.; from about 0.1 to 4 pt. wt.; from about 0.5 to about 2 pt. wt.; from about 1 to about 1.5 pt. wt. per 100 parts per weight of the polymer (A); even from about 0.2 to about 0.5 pt. wt. per 100 pt. wt. of component (A). In another embodiment, the amino acid compound is present in an amount of from about 0.005 to about 0.05 pt. wt. per 100 pt. wt. of component (A). An increase in the amount of amino acid compound as an accelerator may increase the cure rate of curing the surface and decrease the cure time for a tack-free surface and the complete cure through the bulk.

The composition further includes an adhesion promoter component (D) that is different from component (A) or (B). In one embodiment, the adhesion promoter (D) may be an organofunctional silane comprising the group R⁵, e.g., aminosilanes, and other silanes that are not identical to the silanes of component (B), or are present in an amount that exceeds the amount of silanes necessary for endcapping the polymer (A). The amount of non-reacted silane (B) or (D) in the reaction for making (A) can be defined in that after the endcapping reaction the free silanes are evaporated at a higher temperature up to 200° C. and vacuum up to 1 mbar to be more than 0.1 wt. % of (A).

In one embodiment, the composition comprises an adhesion promoter (D) comprising a group R⁵ as described by the general formula (8):

R⁵ _(g)R¹ _(d)Si(R²)_(4-d-g)  (8)

where R⁵ is E-(CR³ ₂)_(h)—W—(CH₂)_(h)—; R¹, R², and d are as described above; g is 1 or 2; d+g=1 to 2; and h is 0 to 8, and may be identical or different.

Non-limiting examples of suitable compounds include:

E¹-(CR³ ₂)_(h)—W—(CH₂)_(h)—SiR¹ _(d)(R²)_(3-d)  (8a) or (8b)

E²-[(CR³ ₂)_(h)—W—(CH₂)_(h)—SiR¹ _(d)(R²)_(3-d)]_(j)  (8c) or (8d)

where j is 2 to 3.

The group E may be selected from either a group E¹ or E². E¹ may be selected from a monovalent group comprising amine, —NH₂, —NHR, —(NHC₂H₅)_(a)NHR, NHC₆H₅, halogen, pseudohalogen, unsaturated aliphatic group with up to 14 carbon atoms, epoxy-group-containing aliphatic group with up to 14 carbon atoms, cyanurate-containing group, and an isocyanurate-containing group.

E² may be selected from a group comprising a di- or multivalent group consisting of amine, polyamine, cyanurate-containing, and an isocyanurate-containing group, sulfide, sulfate, phosphate, phosphite, and a polyorganosiloxane group, which can contain R⁵ and R² groups; W is selected from the group consisting of a single bond, a heteroatomic group selected from —COO—, —O—, epoxy, —S—, —CONH—, —HN—CO—NH— units; R³ is as defined above, R¹ may be identical or different as defined above, R² is defined as above and may be identical or different.

Non-limiting examples of component (D) include:

wherein R¹, R², and d are as defined above. Examples of component (D) include compounds of the formulas (8a-8n). Furthermore the formula (8c) of compounds (D) shall comprise compounds of the formula (8p):

wherein R¹, R², R⁵, and d are as defined above; k is 0 to 6 (and in one embodiment desirably 0); b is as described above (in one embodiment desirably 0 to 5); and 1+b≦10. In one embodiment, R⁵ is selected from:

An exemplary group of adhesion promoters are selected from the group that consists of amino-group-containing silane coupling agents. The amino-group-containing silane adhesion promoter agent (D) is an acidic compound having a group containing a silicon atom bonded to a hydrolyzable group (hereinafter referred to as a hydrolyzable group attached to the silicon atom) and an amino group. Specific examples thereof include the same silyl groups with hydrolyzable groups described above. Among these groups, the methoxy group and ethoxy group are particularly suitable. The number of the hydrolyzable groups may be 2 or more, and particularly suitable are compounds having 3 or more hydrolyzable groups.

Examples of other suitable adhesion promoter (D) include, but are not limited to N-(2-aminoethyl)aminopropyltrimethoxysilane, gamma-aminopropyltriethoxysilane, gamma-aminopropyltrimethoxysilane, bis(3-trimethoxysilypropyl)amine, N-phenyl-gamma-aminopropyltrimethoxysilane, triaminofunctionaltrimethoxysilane, gamma-aminopropylmethyldimethoxysilane, gamma-aminopropylmethyldiethoxysilane, methacryloxypropyltrimethoxysilane, methylaminopropyltrimethoxysilane, gamma-glycidoxypropylethyldimethoxysilane, gamma-glycidoxypropyltrimethoxysilane, gamma-glycidoxyethyltrimethoxysilane, gamma-glycidoxypropylmethyldimethoxysilane, gamma-glycidoxypropylmethyldiethoxysilane, beta-(3,4-epoxycyclohexyl) ethyltrimethoxysilane, beta-(3,4-epoxycyclohexyl) ethylmethyldimethoxysilane, beta-(3,4-epoxycyclohexyl) ethyltriethoxysilane, beta-(3,4-epoxycyclohexyl)ethylmethyldiethoxysilane, epoxylimonyltrimethoxysilane, isocyanatopropyltriethoxysilane, isocyanatopropyltrimethoxysilane, isocyanatopropylmethyldimethoxysilane, beta-cyanoethyltrimethoxysilane, gamma-acryloxypropyltrimethoxysilane, gamma-methacryloxypropylmethyldimethoxysilane, alpha, omega-bis(aminoalkyldiethoxysilyl)polydimethylsiloxanes (Pn=1-7), alpha, omega-bis(aminoalkyldiethoxysilyl) octamethyltetrasiloxane, 4-amino-3,3-dimethylbutyltrimethoxysilane, and N-ethyl-3-trimethoxysilyl-2-methylpropanamine, 3-(N,N-diethylaminopropyl) trimethoxysilane combinations of two or more thereof, and the like. Particularly suitable adhesion promoters include bis(alkyltrialkoxysilyl)amines and tris(alkyltrialkoxysilyl)amines including, but not limited to, bis(3-trimethoxysilylpropyl)amine and tris(3-trimethoxysilylpropyl)amine.

Also it is possible to use derivatives obtained by modifying them, for example, amino-modified silyl polymer, silylated amino polymer, unsaturated aminosilane complex, phenylamino long-chain alkyl silane and aminosilylated silicone. These amino-group-containing silane coupling agents may be used alone, or two or more kinds of them may be used in combination.

The adhesion promoter (D) may be present in an amount of from about 0.1 to about 5.0 pt. wt. based on 100 parts of the polymer component (A). In one embodiment, the adhesion promoter may be present in an amount of from about 0.15 to about 2.0 pt. wt. based on 100 parts of the polymer component (A). In another embodiment, the adhesion promoter may be present in an amount of from about 0.5 to about 1.5 pt. wt of the polymer component (A). This defines the amount of (D) in composition of (A) wherein the content of free silanes coming from the endcapping of polymer (A) is smaller than 0.1 wt. %.

The present compositions may further include a filler component (E). The filler component(s) (E) may have different functions, such as to be used as reinforcing or semi-reinforcing filler, i.e., to achieve higher tensile strength after curing. The filler component may also have the ability to increase viscosity, establish pseudoplasticity/shear thinning, and demonstrate thixotropic behavior. Non-reinforcing fillers may act as volume extenders. The reinforcing fillers are characterized by having a specific surface area of more than 50 m²/g related BET-surface, whereby the semi-reinforcing fillers have a specific surface area in the range of 10-50 m²/g. So-called extending fillers have preferably a specific surface area of less than 10 m²/g according to the BET-method and an average particle diameter below 100 m. In one embodiment, the semi-reinforcing filler is a calcium carbonate filler, a silica filler, or a mixture thereof. Examples of suitable reinforcing fillers include, but are not limited to, fumed silicas or precipitated silicas, which can be partially or completely treated with organosilanes or siloxanes to make them less hydrophilic and decrease the water content or control the viscosity and storage stability of the composition. These fillers are named hydrophobic fillers. Tradenames are Aerosil®, HDK®, Cab-O-Sil® etc.

Examples of suitable extending fillers include, but are not limited to, ground silicas (Celite™), precipitated and colloidal calcium carbonates (which are optionally treated with compounds such as stearate or stearic acid); reinforcing silicas such as fumed silicas, precipitated silicas, silica gels and hydrophobized silicas and silica gels; crushed and ground quartz, cristobalite, alumina, aluminum hydroxide, titanium dioxide, zinc oxide, diatomaceous earth, iron oxide, carbon black, powdered thermoplastics such as acrylonitrile, polyethylene, polypropylene, polytetrafluoroethylene and graphite or clays such as kaolin, bentonite or montmorillonite (treated/untreated), and the like.

The type and amount of filler added depends upon the desired physical properties for the cured silicone/non-silicone composition. As such, the filler may be a single species or a mixture of two or more species. The extending fillers can be present from about 0 to about 300 wt. % of the composition related to 100 parts of component (A). The reinforcing fillers can be present from about 5 to about 60 wt. % of the composition related to 100 parts of component (A), preferably 5 to 30 wt. %.

The inventive compositions optionally comprise an acidic compound (F), which, in conjunction with the adhesion promoter and amino acid based compounds, accelerator, may accelerate curing (as compared to curing in the absence of such compounds). The component (F) may be present in an amount of from about 0.01 to about 5 wt. % of the composition. In another embodiment 0.01 to about 8 parts per weight (pt. wt.) per 100 pt. wt. of component (A) are used, more preferably 0.02 to 3 pt. wt. per 100 pt. wt. of component (A) and most preferably 0.02 to 1 pt. wt. per 100 pt. wt. of component (A) are used.

The acidic compounds (F) may be chosen from various phosphate esters, phosphonates, phosphites, phosphonites, sulfites, sulfates, pseudohalogenides, branched alkyl carboxylic acids, combinations of two or more thereof, and the like. Without being bound to any particular theory, the acidic compounds (F) may, in one embodiment, be useful as stabilizers in order to ensure a longer storage time when sealed in a cartridge before use in contact with ambient air. Especially alkoxy-terminated polysiloxanes can lose the ability to cure after storage in a cartridge and show decreased hardness under curing conditions. It may, therefore be useful to add compounds of the formula (9), which can extend storage time or ability to cure over months,

O═P(OR⁶)_(3-c)(OH)_(c)  (9)

whereby c is as defined above; and R⁶ is selected from the group of linear or branched and optionally substituted C₁-C₃₀ alkyl groups, linear or branched C₅-C₁₄ cycloalkyl groups, C₆-C₁₄ aryl groups, C₆-C₃₁ alkylaryl groups, linear or branched C₂-C₃₀ alkenyl groups or linear or branched C₁-C₃₀ alkoxyalkyl groups, C₄-C₃₀₀ polyalkenylene oxide groups (polyethers), such as Marlophor® N5 acid, triorganylsilyl- and diorganyl (C₁-C₈)-alkoxysilyl groups. The phosphates can include also mixtures of primary and secondary esters. Non-limiting examples of suitable phosphonates include 1-hydroxyethane-(1,1-diphosphonic acid) (HEDP), aminotris(methylene phosphonic acid) (ATMP), diethylenetriaminepenta(methylene phosphonic acid) (DTPMP), 1,2-diaminoethane-tetra(methylene phosphonic acid) (EDTMP), and phosphonobutanetricarboxylic acid (PBTC).

In another embodiment, a compound of the formula O═P(OR⁷)_(3-g)(OH)_(g) may be present or added where g is 1 or 2, and R⁷ is defined as R⁶ or di- or multivalent hydrocarbons with one or more amino group.

Another type are phosphonic acid compounds of the formula R⁶P(O)(OH)₂ such as alkyl phosphonic acids preferably hexyl or octyl phosphonic acid.

In one embodiment, the acidic compound may be chosen from a mono ester of phosphoric acid of the formula (R⁸O)PO(OH)₂; a phosphonic acid of the formula R⁸P(O)(OH)₂; or a monoester of phosphorous acid of the formula (R⁸O)P(OH)₂ where R⁸ is a C₁-C₁₈ alkyl, a C₂-C₂₀ alkoxyalkyl, phenyl, a C₇-C₁₂ alkylaryl, a C₂-C₄ polyalkylene oxide ester or its mixtures with diesters, etc.

In another embodiment, the acidic compound is a branched C₄-C₃₀ alkyl carboxylic acids, including C₅-C₁₉ acids with an alpha tertiary carbon, or a combination of two or more thereof. Examples of such suitable compounds include, but are not limited to, Versatic™ Acid, lauric acid, and stearic acid. In one embodiment, the acidic compound may be a mixture comprising branched alkyl carboxylic acids. In one embodiment, the acidic compound is a mixture of mainly tertiary aliphatic C₁₀ carboxylic acids.

Generally, the acidic component (F) is added in a molar ratio of less than or equal to 1 with respect to accelerator (C). In embodiments, the acidic component (F) is added in a molar ratio of (F):(C) of 1:15 to 1:1.

The curable composition may also include auxiliary substances (G) such as plasticizers, pigments, stabilizers, anti-microbial agents, fungicides, biocides, and/or solvents. Preferred plasticizers for reactive polyorganosiloxanes (A) are selected from the group of polyorganosiloxanes having chain lengths of 10 to 300 siloxy units. Preferred are trimethylsilyl terminated polydimethylsiloxanes having a viscosity of 100 to 1000 mPa·s at 25° C. The choice of optional solvents (dispersion media or extenders) may have a role in assuring uniform dispersion of the accelerator, thereby altering curing speed. Such solvents include polar and non-polar solvents such as toluene, hexane, chloroform, methanol, ethanol, isopropyl alcohol, acetone, methylethyl ketone, dimethylformamide (DMF), dimethyl sulfoxide (DMSO), N-methylpyrrolidinone (NMP), and propylene carbonate. Water can be an additional component (G) to accelerate fast curing 2-part compositions RTV-2, whereby the water can be in one part of the 2 compositions. Particularly suitable non-polar solvents include, but are not limited to, toluene, hexane, and the like if the solvents should evaporate after cure and application. In another embodiment, the solvents include high-boiling hydrocarbons such as alkylbenzenes, phthalic acid esters, arylsulfonic acid esters, trialkyl- or triarylphosphate esters, which have a low vapor pressure and can extend the volume providing lower costs. Examples cited by reference may be those of U.S. Pat. No. 6,599,633; U.S. Pat. No. 4,312,801. The solvent can be present in an amount of from about 20 to about 99 wt. % of the accelerator composition.

Applicants have found that the amino acid based accelerator may provide a curable composition that yields a cured polymer exhibiting a tack-free time, hardness, and/or cure time comparable to compositions made using tin catalysts.

In one embodiment, a composition in accordance with the present invention comprises: 100 pt. wt. polymer component (A); about 0.1 to about 10 pt. wt. crosslinker component (B); and about 0.01 to about 7 pt. wt. accelerator (C).

In one embodiment, the composition further comprises from about 0.1 to about 5, in one embodiment 0.15 to 1 pt. wt., of an adhesion promoter component (D); about 0 to about 300 pt. wt. filler component (E); about 0.01 to about 7 pt. wt. of acidic compound (F); optionally 0 to about 15 pt. wt. component (G), where the pt. wt. of components (B)-(G) are each based on 100 parts of the polymer component (A). In one embodiment, the composition comprises the component (F) in an amount of from about 0.01 to about 1 pt. wt. per 100 pt. wt. of component (A). In still another embodiment, the composition comprises the accelerator (C) in an amount of from about 0.1 to about 0.8 wt. pt. per 100 wt. pt of component (A).

It will be appreciated that the curable compositions may be provided as either a one-part composition or a two-part composition. A one-part composition refers to a composition comprising a mixture of the various components described above. A two-part composition may comprise a first portion and a second portion that are separately stored and subsequently mixed together just prior to application for curing. In one embodiment, a two-part composition comprises a first portion (P1) comprising a polymer component (A) and a crosslinker component (B), and a second portion (P2) comprising the accelerator component (C) comprising the amino acid compound. The first and second portions may include other components (F) and/or (G) as may be desired for a particular purpose or intended use. For example, in one embodiment, the first portion (P1) may optionally comprise an adhesion promoter (D) and/or a filler (E), and the second portion (P2) may optionally comprise auxiliary substances (G), a cure rate modifying component (F), and water (G).

In one embodiment, a two-part composition comprises (i) a first portion comprising the polymer component (A), optionally the filler component (E), and optionally the acidic compound (F); and (ii) a second portion comprising the crosslinker (B), the accelerator component (C), the adhesive promoter (D), and the acidic compound (F), where portions (i) and (ii) are stored separately until applied for curing by mixing of the components (i) and (ii).

An exemplary two-part composition comprises: a first portion (i) comprising 100 pt. wt. of component (A), and 0 to 70 pt. wt. of component (E); and a second portion (ii) comprising 0.1 to 5 pt. wt. of at least one crosslinker (B); 0.01 to 4 pt. wt. of an accelerator (C); 0.1 to 2 pt. wt. of an adhesion promoter (D); and 0.02 to 1 pt. wt. component (F).

The curable compositions may be used in a wide range of applications including as materials for sealing, mold making, glazing, prototyping; as adhesives; as coatings in sanitary rooms; as joint seal between different materials, e.g., sealants between ceramic or mineral surfaces and thermoplastics; as paper release; as impregnation materials; and the like. A curable composition in accordance with the present invention comprising an amino acid compound as an accelerator may be suitable for a wide variety of applications such as, for example, a silicone release coating for substrates including paper and plastic, a weatherstrip coating, a general purpose and industrial sealant, potting compound, caulk, adhesive or coating for construction use, insulated glass, structural glazing, where glass sheets are fixed and sealed in metal frame; caulks, adhesives for metal plates, car bodies, vehicles, electronic devices, and the like. Furthermore, the present composition may be used either as a one-part or as a two-part formulation that can adhere onto broad variety of metal, mineral, ceramic, rubber, or plastic surfaces.

Curable compositions comprising amino acid compounds may be further understood with reference to the following Examples.

Examples

A glass vial containing a magnetic stir bar is charged with an amino acid (N-acetyl-proline), ethyl polysilicate (EPS, 40% condensed), and gamma-aminopropyltrimethoxysilane (GAPTMS). This mixture is stirred with a vortex stirrer for 1 minute then stirred for 3 hours at room temperature. The resulting solutions are clear and allowed to stand at room temperature for up to two days. Formulations of Examples 1-5 and Comparative Example 1 are listed in Table 1 below.

TABLE 1 Formulations of Amino Acid containing Condensation Cure Systems. Example CE1 Ex1 Ex2 Ex3 Ex4 Ex5 N-AcPro (g) 0 0.13 0.26 0.28 0.5 1 GAPTMS (g) 7.5 7.5 7.5 7.5 7.5 7.5 EPS (g) 6.5 6.5 6.5 6.5 6.5 6.5 Appearance clear clear clear clear clear clear color color- color- color- color- color- color- less less less less less less

Measurement and Testing

To a 100-gram speed-mixing cup is added a blended mixture of polymer and filler. A reactive solution (Ex1-5 or CE1) is then added and the mixture is speed-mixed on a Hauschild speed-mixer for 30 seconds at 800 rpm and for 35 seconds at 1600 rpm. Samples are then exposed to ambient conditions and tested for snap time and physical properties as described below.

Various properties of the curable compositions are evaluated as follows: snap time is determined according to a modified procedure for WPS™ E-31a; sealant sheet physical properties were determined according to WPS™ E-1, issue number 12; sealant indentation hardness was determined according to WPS™ E-3, issue number 13; cohesive failure and tensile adhesion properties were determined according to ASTM#C-1135-00.

The properties of curable compositions for the examples are shown in Table 2.

TABLE 2 Experimental data for N-Acetyl-l-Proline based condensation cure systems Example CE1 Ex1 Ex2 Ex3 Ex4 Ex5 Snap 30 17 20 25 25 50 Hardness 26 28 30 25 21 30 (Shore A) Sheets Tensile 216 226 204 196 207 192 strength at break (psi) 50% 59 58 54 51 44 40 Modulus (psi) 100% 105 107 98 88 80 80 Modulus (psi) Elongation 210 198 204 225 243 232 at break (%) 21 d Cohesive 100 100 100 100 100 100 C1135 failure to Glass (%) Cohesive 100 98 100 100 100 100 failure to Aluminum (%) Tensile 83 86 96 89 86 76 strength at break (psi) Elongation 103 104 128 104 136 132 at break (%)

Embodiments of the invention have been described above and modifications and alterations may occur to others upon the reading and understanding of this specification. The claims as follows are intended to include all modifications and alterations insofar as they come within the scope of the claims or the equivalent thereof. 

1. A composition for forming a curable polymer composition comprising: (A) a polymer having at least a reactive silyl group; (B) a crosslinker or chain extender; and (C) a condensation accelerator comprising an amino acid compound.
 2. The composition of claim 1, wherein the amino acid compound comprises at least one group attached to the N-terminus that is a group other than hydrogen.
 3. The composition of claim 1, wherein the amino acid compound comprises an amino acid substituted at the O-terminus with a group other than hydrogen.
 4. The composition of claim 1, wherein the amino acid compound comprises a compound of the formula (6):

wherein Q is selected from

an aliphatic heterocyclic compound containing at least one nitrogen atom of the formula:

where t is an integer from 1 to 6; or an aromatic heterocyclic compound containing at least one nitrogen atom; where R⁹, R¹⁰, and R¹¹ are independently selected from hydrogen, a linear or branched alkyl, a linear or branched heteroalkyl, an aryl, a heteroaryl, a cycloalkyl, a heterocycloalkyl, a linear or branched aralkyl, or a linear or branched heteroaralkyl, a silyl group, as siloxy group, or a combination of two or more thereof; R¹² and R¹³ are independently selected from hydrogen, a linear or branched alkyl, a cycloalkyl, an aryl, a heteroaryl, a linear or branched aralkyl, a linear or branched heteroaralkyl, a silyl group, a siloxy group, a functional group of the formula,

or a functional group of the formula

where X is either O or S; and R¹⁴ and R¹⁵ are independently selected from hydrogen, a linear or branched alkyl, a cycloalkyl, an aryl, a heteroaryl, a linear or branched aralkyl, a linear or branched heteroaralkyl, OR¹⁶, NR₂ ¹⁶, or SR¹⁶; and R¹⁶ is chosen from hydrogen, a linear or branched alkyl, a cycloalkyl, an aryl, a heteroaryl, a linear or branched aralkyl, a linear or branched heteroaralkyl, an acyl group, a thioacyl group, or a combination of two or more thereof, and R¹⁶ groups may be similar or different.
 5. The composition of claim 4, wherein R⁹ is a group other than hydrogen, R¹² is a group other than hydrogen, or both R⁹ and R¹² is a group other than hydrogen.
 6. The composition of claim 4, wherein at least one of R¹² and R¹³ is chosen from a functional group of the formula:


7. The composition of claim 6, wherein X is O, and R¹⁴ is a C₁-C₆ alkyl group.
 8. The composition of claim 6, wherein R¹² is an acetyl.
 9. The composition of claim 1, wherein the amino acid comprises a compound of the formula:


10. The composition of claim 1, wherein the amino acid is chosen from N-acetyl-glycine, N-acetyl-alanine, N-acetyl-valine, N-acetyl-leucine, N-acetyl-isoleucine, N-acetyl-serine, N-acetyl-threonine, N-acetyl-cysteine, N-acetyl-methionine, N-acetyl-aspartic acid, N-acetyl-asparagine, N-acetyl-glutamic acid, N-acetyl-glutamine, N-acetyl-arginine, N-acetyl-lysine, N-acetyl-histidine, N-acetyl-phenylalanine, N-acetyl-tyrosine, N-acetyl-tryptophan, N-acetyl-proline, N-acetyl-taurine, N-acetyl-hydroxyproline, N-acetyl-canavanine, N-acetyl-hydroxylysine, N-acetyl-cycloserine, N-acetyl-homoarginine, N-acetyl-norleucine, N-acetyl-norvaline, N-acetyl-homoserine, N-acetyl-methylserine, N-acetyl-hydroxyvaline, N-acetyl-ethionine, N-acetyl-methoxinine, N-acetyl-β-aminoisobutanoic acid, N-acetyl-homocysteine, N-acetyl-cysteine sulfinic acid, N-acetyl-homophenylalanine, N-acetyl-homotryptophan, N-acetyl-hydroxytryptamine (N-acetylserotonin), N-acetyl-tryptamine, N-acetyl-ornithine, N-acetyl-citrulline, N-acetyl-argininosuccinic acid, N-acetyl-dopa, N-acetyl-3-iodotyrosine, N-acetyl-3,5-diiodotyrosine, N-acetyl-3,5,3′-triiodothyronine, N-acetyl-thyroxine, N-acetyl-creatine, N-acetyl-creatinine, N-acetyl-cystine and N-acetyl-homocystine, or a combination of two or more thereof.
 11. The composition of claim 1, wherein the amino acid compound is chosen from glycine trimethylsilyl ester, alanine trimethylsilyl ester, d-alanine trimethylsilyl ester, glycine tert-butyldimethylsilyl ester, 1-serine trimethylsilyl ester, valine trimethylsilyl ester, norvaline trimethylsilyl ester, isoleucine trimethylsilyl ester, 1H-imidazole-1-acetic acid trimethylsilyl ester, 2-pyridinecarboxylic acid trimethylsilyl ester, proline trimethylsilyl ester, 2-piperidinecarboxylic acid trimethylsilyl ester, or a combination of two or more thereof.
 12. The composition of claim 1, wherein the amino acid compound is chosen from N-acetyl-glycine trimethylsilyl ester, N-(trifluoroacetyl)-1-leucine trimethylsilyl ester, or a combination of two or more thereof.
 13. The composition of claim 1, wherein the amino acid compound is chosen from 2-methyl-(N-(trimethylsilyl)-alanine trimethylsilyl ester, S-ethyl-N-(trimethylsilyl)-homocysteine trimethylsilyl ester, 1-(trimethylsilyl)-1H-indole2-carboxylic acid trimethylsilyl ester, or a combination of two or more thereof.
 14. The composition of claim 1, wherein the amino acid compound is chosen from 2-[bis(trimethylsilyl)amino]-butanoic acid trimethylsilyl ester, or a combination of two or more thereof.
 15. The composition of claim 1, wherein the amino acid compound is chosen from glycine bis(trimethylsiloxy)methylsilyl ester, alanine bis(trimethylsiloxy)methylsilyl ester, valine bis(trimethylsiloxy)methylsilyl ester, leucine bis(trimethylsiloxy)methylsilyl ester, glycine dimethyl(trimethylsiloxy)silyl ester, alanine dimethyl(trimethylsiloxy)silyl ester, valine dimethyl(trimethylsiloxy)silyl ester, leucine dimethyl(trimethylsiloxy)silyl ester, or a combination of two or more thereof.
 16. The composition of claim 1, wherein the amino acid compound comprises N-acetyl-proline.
 17. The composition of claim 1 comprising from about 0.001 to about 10 parts per weight of accelerator (C) per 100 parts per weight of the polymer (A).
 18. The composition of claim 1 comprising from about 0.1 to about 5 wt. pt. of accelerator (C) per 100 parts of the polymer A.
 19. The composition of claim 1, wherein the accelerator (C) is substantially free of tin.
 20. The composition of claim 1, wherein the accelerator (C) further comprises a blend of metal accelerator, a salt of a metal accelerator, a carboxylic acid, an alkyl-sulfonic acid, an aryl sulfonic acid, an inorganic acid, an amine, a guanidine, an amidine, an inorganic base, or a combination of two or more thereof.
 21. The composition of claim 1, wherein the polymer (A) has the formula (1): [R¹ _(a)R² _(3-a)Si—Z—]_(n)—X—Z—SiR¹ _(a)R² _(3-a)  (1) where X is chosen from a polyurethane; a polyester; a polyether; a polycarbonate; a polyolefin; a polyesterether; and a polyorganosiloxane having units of R₃SiO_(1/2), R₂SiO, RSiO_(3/2), and/or SiO₂; n is 0 to 100; a is 0 to 2; R¹ can be identical or different at the same Si-atom and chosen from a C₁-C₁₀ alkyl; a C₁-C₁₀ alkyl substituted with one or more of Cl, F, N, O or S; a phenyl; a C₇-C₁₆ alkylaryl; a C₇-C₁₆ arylalkyl; a C₂-C₄ polyalkylene ether; or a combination of two or more thereof; R² is chosen from OH, C₁-C₈ alkoxy, C₂-C₁₈ alkoxyalkyl, oximoalkyl, enoxyalkyl, aminoalkyl, carboxyalkyl, amidoalkyl, amidoaryl, carbamatoalkyl, or a combination of two or more thereof; and Z is a bond, a divalent unit selected from the group of a C₁-C₈ alkylene, or O.
 22. The polymer composition of claim 1 wherein the polymer component (A) has the formula (2): R² _(3-c)R¹ _(c)Si—Z—[R₂SiO]_(x)[R¹ ₂SiO]_(y)—Z—SiR¹ _(c)R² _(3-c)  (2) where R¹ can be identical or different at the same Si-atom and chosen from a C₁-C₁₀ alkyl; a C₁-C₁₀ alkyl substituted with one or more of Cl, F, N, O or S; a phenyl; a C₇-C₁₆ alkylaryl; a C₇-C₁₆ arylalkyl; a C₂-C₄ polyalkylene ether; or a combination of two or more thereof; R² is chosen from OH, C₁-C₈ alkoxy, C₂-C₁₈ alkoxyalkyl, oximoalkyl, enoxyalkyl, aminoalkyl, carboxyalkyl, amidoalkyl, amidoaryl, carbamatoalkyl, or a combination of two or more thereof; Z is a bond, a divalent unit selected from the group of a C₁-C₈ alkylene, or O; R is C₁-C₆ alkyl (an exemplary alkyl being methyl); x is 0 to about 10,000, in one embodiment from 11 to about 2500; and y is 0 to about 10,000; preferably 0 to
 500. In one embodiment, Z in a compound of formula (2) is a bond or a divalent C₁-C₁₄ alkylene group, especially preferred is —C₂H₄—.
 23. The polymer composition of claim 1 wherein the polymer component (A) has the formula (3): R² _(3-c-d)SiR³ _(c)R⁴ _(d)—[OSiR³R⁴]_(x)—[OSiR³R⁴]_(y)—OSiR³ _(e)R⁴ _(f)R² _(3-e-f)  (3) where x is 0 to 10000; y is 0 to 1000; c, d, and f are independently chosen from 0 to 2; R¹ is chosen from a C₁-C₁₀ alkyl; a C₁-C₁₀ alkyl substituted with one or more of Cl, F, N, O, or S; a phenyl; a C₇-C₁₆ alkylaryl; a C₇-C₁₆ arylalkyl; a C₂-C₄ polyalkylene ether; or a combination of two or more thereof, and other siloxane units may be present in amounts less than 10 mol. % preferably methyl, vinyl, phenyl; R² is chosen from OH, a C₁-C₈ alkoxy, a C₂-C₁₈ alkoxyalkyl, an oximoalkyl, an oximoaryl, an enoxyalkyl, an enoxyaryl, an aminoalkyl, an aminoaryl, a carboxyalkyl, a carboxyaryl, an amidoalkyl, an amidoaryl, a carbamatoalkyl, a carbamatoaryl, or a combination of two or more thereof; and Z is —O—, a bond, or —C₂H₄—; and R³ and R⁴ can be identical or different on the same silicon atom and are chosen from hydrogen; C₁-C₁₀ alkyl; C₁-C₁₀ heteroalkyl, C₃-C₁₂ cycloalkyl; C₂-C₃₀ heterocycloalkyl; C₆-C₁₃ aryl; C₇-C₃₀ alkylaryl; C₇-C₃₀ arylalkyl; C₄-C₁₂ heteroaryl; C₅-C₃₀ heteroarylalkyl; C₅-C₃₀ heteroalkylaryl; C₂-C₁₀₀ polyalkylene ether; or a combination of two or more thereof.
 24. The composition of claim 1, wherein the polymer (A) is chosen from silylated polyurethane (SPUR), silylated polyester, silylated polyether, silylated polycarbonate, silylated polyolefins like polyethylene, polypropylene, silylated polyesterether and combinations of two or more thereof.
 25. The composition of claim 1, wherein the crosslinker or chain extender (B) is chosen from an alkoxysilane, an alkoxysiloxane, an oximosilane, an oximosiloxane, an enoxysilane, an enoxysiloxane, an aminosilane, an aminosiloxane, a carboxysilane, a carboxysiloxane, an alkylamidosilane, an alkylamidosiloxane, an arylamidosilane, an arylamidosiloxane, an alkoxyaminosilane, an alklarylaminosiloxane, an alkoxycarbamatosilane, an alkoxycarbamatosiloxane, or a combination of two or more thereof.
 26. The composition of claim 1, wherein the crosslinker or chain extender (B) is chosen from tetraethylorthosilicate (TEOS); methyltrimethoxysilane (MTMS); methyltriethoxysilane; vinyltrimethoxysilane; vinyltriethoxysilane; methylphenyldimethoxysilane; 3,3,3-trifluoropropyltrimethoxysilane; methyltriacetoxysilane; vinyltriacetoxysilane; ethyltriacetoxysilane; di-butoxydiacetoxysilane; phenyltripropionoxysilane; methyltris(methylethylketoximo)silane; vinyltris(methylethylketoximo)silane; 3,3,3-trifluoropropyltris(methylethylketoximo)silane; methyltris(isopropenoxy)silane; vinyltris(isopropenoxy)silane; ethylpolysilicate; dimethyltetraacetoxydisiloxane; tetra-n-propylorthosilicate; methyldimethoxy(ethylmethylketoximo)silane; methylmethoxybis(ethylmethylketoximo)silane; methyldimethoxy(acetaldoximo)silane; methyldimethoxy(N-methylcarbamato)silane; ethyldimethoxy(N-methylcarbamato)silane; methyldimethoxyisopropenoxysilane; trimethoxyisopropenoxysilane; methyltriisopropenoxysilane; methyldimethoxy(but-2-en-2-oxy)silane; methyldimethoxy(1-phenylethenoxy)silane; methyldimethoxy-2-(1-carboethoxypropenoxy)silane; methylmethoxydi(N-methylamino)silane; vinyldimethoxy(methylamino)silane; tetra-N,N-diethylaminosilane; methyldimethoxy(methylamino)silane; methyltri(cyclohexylamino)silane; methyldimethoxy(ethylamino)silane; dimethyldi(N,N-dimethylamino)silane; methyldimethoxy(isopropylamino)silane; dimethyldi(N,N-diethylamino)silane; ethyldimethoxy(N-ethylpropionamido)silane; methyldimethoxy(N-methylacetamido)silane; methyltris(N-methylacetamido)silane; ethyldimethoxy(N-methylacetamido)silane; methyltris(N-methylbenzamido)silane; methylmethoxybis(N-methylacetamido)silane; methyldimethoxy(caprolactamo)silane; trimethoxy(N-methylacetamido)silane; methyldimethoxy(ethylacetimidato)silane; methyldimethoxy(propylacetimidato)silane; methyldimethoxy(N,N′N′-trimethylureido)silane; methyldimethoxy(N-allyl-N′,N′-dimethylureido)silane; methyldimethoxy(N-phenyl-N′,N′-dimethylureido)silane; methyldimethoxyisocyanatosilane; dimethoxydiisocyanatosilane; methyldimethoxyisothiocyanatosilane; methylmethoxydiisothiocyanatosilane, the condensates thereof, or a combination of two or more thereof.
 27. The composition of claim 1 comprising an adhesion promoter component (D), chosen from an (aminoalkyl)trialkoxysilane, an (aminoalkyl)alkyldialkoxysilane, a bis(trialkoxysilylalkyl)amine, a tris(trialkoxysilylalkyl)amine, a tris(trialkoxysilylalkyl)cyanurate, a tris(trialkoxysilylalkyl)isocyanurate, an (epoxyalkyl)alkyldialkoxysilane, an (epoxyalkyl)trialkoxysilane, or a combination of two or more thereof.
 28. The composition of claim 1 comprising a filler component (E).
 29. The composition of claim 1 comprising at least one acidic compound (F) chosen from a phosphate ester, a phosphonate ester, a phosphonic acid, a phosphorous acid, a phosphite, a phosphonite ester, a sulfate, a sulfite, a pseudohalogenide, a branched C₄-C₂₅ alkyl carboxylic acid, or a combination of two or more thereof.
 30. The composition of claim 1, wherein the composition is a two-part composition comprising: (i) a first portion comprising the polymer component (A), optionally the filler component (E), and optionally the acidic compound (F); and (ii) a second portion comprising the crosslinker (B), the accelerator (C), the adhesion promoter (D), and the acidic compound (F), whereby (i) and (ii) are stored separately until applied for curing by mixing of the components (i) and (ii).
 31. A cured polymer formed from the composition or method of claim
 1. 32. The cured polymer of claim 31 in the form of an elastomeric seal, duromeric seal, an adhesive, a coating, an encapsulant, a shaped article, a mold, an impression material, an optical material, or a silicone foam.
 33. A cured polymer composition comprising: a compound having at least one hydridosilyl group, and a condensation cure accelerator comprising an amino acid based compound.
 34. The composition of claim 33, wherein the amino acid compound comprises at least one group attached to the N-terminus that is a group other than hydrogen.
 35. The composition of claim 33, wherein the amino acid compound comprises an amino acid substituted at the O-terminus with a group other than hydrogen.
 36. The composition of claim 33, wherein the amino acid compound comprises a compound of the formula (6):

wherein Q is selected from

an aliphatic heterocyclic compound containing at least one nitrogen atom of the formula:

where t is an integer from 1 to 6; or an aromatic heterocyclic compound containing at least one nitrogen atom; where R⁹, R¹⁰, and R¹¹ are independently selected from hydrogen, a linear or branched alkyl, a linear or branched heteroalkyl, an aryl, a heteroaryl, a cycloalkyl, a heterocycloalkyl, a linear or branched aralkyl, or a linear or branched heteroaralkyl, a silyl group, as siloxy group, or a combination of two or more thereof; R¹² and R¹³ are independently selected from hydrogen, a linear or branched alkyl, a cycloalkyl, an aryl, a heteroaryl, a linear or branched aralkyl, a linear or branched heteroaralkyl, a silyl group, a siloxy group, a functional group of the formula,

or a functional group of the formula

where X is either O or S; and R¹⁴ and R¹⁵ are independently selected from hydrogen, a linear or branched alkyl, a cycloalkyl, an aryl, a heteroaryl, a linear or branched aralkyl, a linear or branched heteroaralkyl, OR¹⁶, NR₂ ¹⁶, or SR¹⁶; and R¹⁶ is chosen from hydrogen, a linear or branched alkyl, a cycloalkyl, an aryl, a heteroaryl, a linear or branched aralkyl, a linear or branched heteroaralkyl, an acyl group, a thioacyl group, or a combination of two or more thereof, and R¹⁶ groups may be similar or different.
 37. The composition of claim 36, wherein R⁹ is a group other than hydrogen, R¹² is a group other than hydrogen, or both R⁹ and R¹² is a group other than hydrogen.
 38. The composition of claim 36, wherein at least one of R¹² and R¹³ is chosen from a functional group of the formula:


39. The composition of claim 38, wherein X is O, and R¹⁴ is a C₁-C₆ alkyl group.
 40. The composition of claim 38, wherein R¹² is an acetyl.
 41. The composition of claim 33, wherein the amino acid comprises a compound of the formula:


42. The composition of claim 33, wherein the amino acid is chosen from N-acetyl-glycine, N-acetyl-alanine, N-acetyl-valine, N-acetyl-leucine, N-acetyl-isoleucine, N-acetyl-serine, N-acetyl-threonine, N-acetyl-cysteine, N-acetyl-methionine, N-acetyl-aspartic acid, N-acetyl-asparagine, N-acetyl-glutamic acid, N-acetyl-glutamine, N-acetyl-arginine, N-acetyl-lysine, N-acetyl-histidine, N-acetyl-phenylalanine, N-acetyl-tyrosine, N-acetyl-tryptophan, N-acetyl-proline, N-acetyl-taurine, N-acetyl-hydroxyproline, N-acetyl-canavanine, N-acetyl-hydroxylysine, N-acetyl-cycloserine, N-acetyl-homoarginine, N-acetyl-norleucine, N-acetyl-norvaline, N-acetyl-homoserine, N-acetyl-methylserine, N-acetyl-hydroxyvaline, N-acetyl-ethionine, N-acetyl-methoxinine, N-acetyl-β-aminoisobutanoic acid, N-acetyl-homocysteine, N-acetyl-cysteine sulfinic acid, N-acetyl-homophenylalanine, N-acetyl-homotryptophan, N-acetyl-hydroxytryptamine (N-acetylserotonin), N-acetyl-tryptamine, N-acetyl-ornithine, N-acetyl-citrulline, N-acetyl-argininosuccinic acid, N-acetyl-dopa, N-acetyl-3-iodotyrosine, N-acetyl-3,5-diiodotyrosine, N-acetyl-3,5,3′-triiodothyronine, N-acetyl-thyroxine, N-acetyl-creatine, N-acetyl-creatinine, N-acetyl-cystine and N-acetyl-homocystine, or a combination of two or more thereof.
 43. The composition of claim 33, wherein the amino acid compound is chosen from glycine trmethylsilyl ester, alanine trimethylsilyl ester, d-alanine trimethylsilyl ester, glycine tert-butyldimethylsilyl ester, 1-serine trimethylsilyl ester, valine trimethylsilyl ester, norvaline trimethylsilyl ester, isoleucine trimethylsilyl ester, 1H-imidazole-1-acetic acid trimethylsilyl ester, 2-pyridinecarboxylic acid trimethylsilyl ester, proline trimethylsilyl ester, 2-piperidinecarboxylic acid trimethylsilyl ester, or a combination of two or more thereof.
 44. The composition of claim 33, wherein the amino acid compound is chosen from N-acetyl-glycine trimethylsilyl ester, N-(trifluoroacetyl)-1-leucine trimethylsilyl ester, or a combination of two or more thereof.
 45. The composition of claim 33, wherein the amino acid compound is chosen from 2-methyl-(N-(trimethylsilyl)-alanine trimethylsilyl ester, S-ethyl-N-(trimethylsilyl)-homocysteine trimethylsilyl ester, 1-(trimethylsilyl)-1H-indole2-carboxylic acid trimethylsilyl ester, or a combination of two or more thereof.
 46. The composition of claim 33, wherein the amino acid compound is chosen from 2-[bis(trimethylsilyl)amino]-butanoic acid trimethylsilyl ester, or a combination of two or more thereof.
 47. The composition of claim 33, wherein the amino acid compound is chosen from glycine bis(trimethylsiloxy)methylsilyl ester, alanine bis(trimethylsiloxy)methylsilyl ester, valine bis(trimethylsiloxy)methylsilyl ester, leucine bis(trimethylsiloxy)methylsilyl ester, glycine dimethyl(trimethylsiloxy)silyl ester, alanine dimethyl(trimethylsiloxy)silyl ester, valine dimethyl(trimethylsiloxy)silyl ester, leucine dimethyl(trimetllylsiloxy)silyl ester, or a combination of two or more thereof.
 48. The composition of claim 33, wherein the amino acid compound comprises N-acetyl-proline.
 49. The composition of claim 33 comprising from about 0.001 to about 10 parts per weight of accelerator per 100 parts per weight of the compound having at least one hydrosilyl group.
 50. The composition of claim 33 comprising from about 0.1 to about 5 wt. pt. of accelerator per 100 parts of the having at least one hydrosilyl group.
 51. The composition of claim 33, wherein the accelerator is substantially free of tin.
 52. The composition of claim 33, wherein the accelerator (C) further comprises a blend of metal accelerator, a salt of a metal accelerator, a carboxylic acid, an alkyl-sulfonic acid, an aryl sulfonic acid, an inorganic acid, an amine, a guanidine, an amidine, an inorganic base, or a combination of two or more thereof. 